×
AbbVie Other Income 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie other income for the twelve months ending March 31, 2026 was
$0M
, a
0% increase
year-over-year.
AbbVie annual other income for 2024 was
$0B
, a
0% decline
from 2023.
AbbVie annual other income for 2023 was
$0B
, a
0% decline
from 2022.
AbbVie annual other income for 2022 was
$0B
, a
0% decline
from 2021.
View More
AbbVie Other Income 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie annual other income for 2024 was
$0B
, a
0% decline
from 2023.
AbbVie annual other income for 2023 was
$0B
, a
0% decline
from 2022.
AbbVie annual other income for 2022 was
$0B
, a
0% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B